The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis
Open accessAbstract
Summary p97 is a AAA-ATPase with multiple cellular functions, one of which is critical regulation of protein homeostasis pathways. We describe the characterization of CB-5083, a potent, selective and orally bioavailable inhibitor of p97. Treatment of tumor cells with CB-5083 leads to accumulation of poly-ubiquitinated proteins, retention of endoplasmic reticulum associated degradation (ERAD) substrates and generation of irresolvable proteotoxic stress leading to activation of the apoptotic arm of the unfolded protein response (UPR). In xenograft models, CB-5083 causes modulation of key p97-related pathways, induces apoptosis and has antitumor activity in a broad range of both hematological and solid tumor models. Molecular determinants of CB-5083 activity include expression of genes in the ERAD pathway providing a potential strategy for patient selection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The control of the false discovery rate in multiple testing under dependency
Benjamini, Y., & Yekutieli, D. (2001) · The Annals of Statistics · doi:10.1214/aos/1013699998 · Cited by 10,490
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728
Self-citationTumour heterogeneity and cancer cell plasticity
Meacham, C. E., & Morrison, S. J. (2013) · Nature · doi:10.1038/nature12624 · Cited by 2,446
Impairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N. F., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,187
ER stress-induced cell death mechanisms
Sano, R., & Reed, J. C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.028 · Cited by 1,988
Autophagy Is Activated for Cell Survival after Endoplasmic ReticulumStress
Ogata, M., Hino, S.-I., Saito, A., Morikawa, K., Kondo, S., Kanemoto, S., Murakami, T., Taniguchi, M., Tanii, I., Yoshinaga, K., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01453-06 · Cited by 1,832
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
Hideshima, T., Richardson, P. G. G., Chauhan, D., Palombella, V. J., Elliott, P. J., Adams, J., & Anderson, K. C. (2001) · PubMed · Cited by 1,508
Yamamoto, A., Tagawa, Y., Yoshimori, T., Moriyama, Y., Masaki, R., & Tashiro, Y. (1998) · Cell Structure and Function · doi:10.1247/csf.23.33 · Cited by 1,312
The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol
Ye, Y., Meyer, H. H., & Rapoport, T. A. (2001) · Nature · doi:10.1038/414652a · Cited by 1,099
Yoshida, H., Okada, T., Haze, K., Yanagi, H., Yura, T., Negishi, M., & Mori, K. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.18.6755-6767.2000 · Cited by 934
Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system
Meyer, H., Bug, M., & Bremer, S. (2012) · Nature Cell Biology · doi:10.1038/ncb2407 · Cited by 807
Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis
Lu, M., Lawrence, D. A., Marsters, S., Acosta-Alvear, D., Kimmig, P., Mendez, A. S., Paton, A. W., Paton, J. C., Walter, P., & Ashkenazi, A. (2014) · Science · doi:10.1126/science.1254312 · Cited by 567
Rabinovich, E., Kerem, A., Fröhlich, K.-U., Diamant, N., & Bar-Nun, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.626-634.2002 · Cited by 546
Evaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Kupperman, E., Lee, E. C., Cao, Y., Bannerman, B., Fitzgerald, M., Berger, A., Yu, J., Yang, Y., Hales, P., Bruzzese, F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2766 · Cited by 499
Self-citationValosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease
Ju, J.-S., Fuentealba, R. A., Miller, S. E., Jackson, E., Piwnica-Worms, D., Baloh, R. H., & Weihl, C. C. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200908115 · Cited by 494
The proteasome inhibitor PS-341 in cancer therapy.
Teicher, B. A., Ara, G., Herbst, R. S., Palombella, V. J., & Adams, J. (1999) · PubMed · Cited by 472
Oda, Y., Okada, T., Yoshida, H., Kaufman, R. J., Nagata, K., & Mori, K. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200507057 · Cited by 379
Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death
Magnaghi, P., D'Alessio, R., Valsasina, B., Avanzi, N., Rizzi, S., Asa, D., Gasparri, F., Cozzi, L., Cucchi, U., Orrenius, C., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1313 · Cited by 373
Self-citationMorris, J. A., Dorner, A. J., Edwards, C. A., Hendershot, L. M., & Kaufman, R. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4327 · Cited by 352
Cole, A., Wang, Z., Coyaud, E., Voisin, V., Gronda, M., Jitkova, Y., Mattson, R., Hurren, R., Babovic, S., Maclean, N., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.05.004 · Cited by 352
Self-citationIn Situ Kinase Profiling Reveals Functionally Relevant Properties of Native Kinases
Patricelli, M. P., Nomanbhoy, T. K., Wu, J., Brown, H., Zhou, D., Zhang, J., Jagannathan, S., Aban, A., Okerberg, E., Herring, C., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.04.011 · Cited by 348
Wang, Q., Mora-Jensen, H., Weniger, M. A., Perez-Galan, P., Wolford, C., Hai, T., Ron, D., Chen, W., Trenkle, W., Wiestner, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807611106 · Cited by 343
Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy
Deshaies, R. J. (2014) · BMC Biology · doi:10.1186/s12915-014-0094-0 · Cited by 337
Song, B.-L., Sever, N., & DeBose-Boyd, R. A. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.08.009 · Cited by 328
Chou, T.-F., Brown, S. J., Minond, D., Nordin, B. E., Li, K., Jones, A. C., Chase, P., Porubsky, P. R., Stoltz, B. M., Schoenen, F. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015312108 · Cited by 324
p62/SQSTM1: A Missing Link between Protein Aggregates and the Autophagy Machinery
Bjørkøy, G., Lamark, T., & Johansen, T. (2006) · Autophagy · doi:10.4161/auto.2.2.2405 · Cited by 322
Dasgupta, B., Yi, Y., Chen, D. Y., Weber, J. D., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4058 · Cited by 308
Mechanism-based cancer therapy: resistance to therapy, therapy for resistance
Ramos, P., & Bentires-Alj, M. (2015) · Oncogene · doi:10.1038/onc.2014.314 · Cited by 272
The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks
Meerang, M., Ritz, D., Paliwal, S., Garajova, Z., Bosshard, M., Mailand, N., Janscak, P., Hübscher, U., Meyer, H., & Ramadan, K. (2011) · Nature Cell Biology · doi:10.1038/ncb2367 · Cited by 254
Novel Proteasome Inhibitors to Overcome Bortezomib Resistance
Ruschak, A. M., Slassi, M., Kay, L. E., & Schimmer, A. D. (2011) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr160 · Cited by 243
Central Pore Residues Mediate the p97/VCP Activity Required for ERAD
DeLaBarre, B., Christianson, J. C., Kopito, R. R., & Brunger, A. T. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.036 · Cited by 203
ATPase Activity of p97-Valosin-containing Protein (VCP)
Song, C., Wang, Q., & Li, C.-C. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208422200 · Cited by 200
Distinct Roles for the AAA ATPases NSF and p97 in the Secretory Pathway
Dalal, S., Rosser, M. F. N., Cyr, D. M., & Hanson, P. I. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0097 · Cited by 182
Aneuploidy: implications for protein homeostasis and disease
Oromendia, A. B., & Amon, A. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.013391 · Cited by 166
Wang, Q., Shinkre, B. A., Lee, J.-G., Weniger, M. A., Liu, Y., Chen, W., Wiestner, A., Trenkle, W. C., & Ye, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015479 · Cited by 161
Using transcriptome sequencing to identify mechanisms of drug action and resistance
Wacker, S. A., Houghtaling, B. R., Elemento, O., & Kapoor, T. M. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.779 · Cited by 160
Chou, T., Li, K., Frankowski, K. J., Schoenen, F. J., & Deshaies, R. J. (2013) · ChemMedChem · doi:10.1002/cmdc.201200520 · Cited by 149
ATP-Competitive Inhibitors of mTOR: An Update
Schenone, S., Brullo, C., Musumeci, F., Radi, M., & Botta, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796391651 · Cited by 142
The ubiquitin–proteasome system: opportunities for therapeutic intervention in solid tumors
Johnson, D. E. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0005 · Cited by 107
Expanding into new markets – VCP/p97 in endocytosis and autophagy
Bug, M., & Meyer, H. H. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.03.003 · Cited by 103
Combination Therapy of Bortezomib with Novel Targeted Agents: An Emerging Treatment Strategy
Wright, J. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2882 · Cited by 95
Generation of drug-resistant variants in metastatic B16 mouse melanoma cell lines.
Cillo, C., Dick, J. E., Ling, V., & Hill, R. P. (1987) · PubMed · Cited by 81
Emerging insights into resistance to BRAF inhibitors in melanoma
Bucheit, A. D., & Davies, M. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.013 · Cited by 77
P97/CDC-48: Proteostasis control in tumor cell biology
Fessart, D., Marza, E., Taouji, S., Delom, F., & Chevet, É. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.030 · Cited by 74
Morris, L. L., Hartman, I. Z., Jun, D., Seemann, J., & DeBose‐Boyd, R. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.576652 · Cited by 56
Protein folding, protein homeostasis, and cancer
Drie, J. H. V. (2011) · 癌症:英文版 · doi:10.5732/cjc.010.10162 · Cited by 50
Nguyen, T. K., & Grant, S. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0714 · Cited by 41
Fang, C., Gui, L., Zhang, X., Moen, D. R., Li, K., Frankowski, K. J., Lin, H. J., Schoenen, F. J., & Chou, T. (2014) · ChemMedChem · doi:10.1002/cmdc.201402420 · Cited by 32
Zhang, L., Pham, L. V., Newberry, K. J., Ou, Z., Liang, R., Qian, J., Sun, L., Blonska, M., You, Y., Yang, J., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0156 · Cited by 26
The ubiquitin–proteasome system as a molecular target in solid tumors: an update on bortezomib
Caponigro, F., & Milano, A. (2009) · OncoTargets and Therapy · doi:10.2147/ott.s4503 · Cited by 21
Signalling pathways which regulate eIF4E
Flynn, A., Vries, R. G. J., & Proud, C. G. (1997) · Biochemical Society Transactions · doi:10.1042/bst025192s · Cited by 17
Inhibition of Ubiquitin Proteasome System Enzymes for Anticancer Therapy
Wustrow, D. J., Zhou, H.-J., & Rolfe, M. (2013) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-417150-3.00014-4 · Cited by 11
Self-citation
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1
Klionsky, D. J., Abdel-Aziz, A. K., Abdelfatah, S., Abdellatif, M., Abdoli, A., Abel, S., Abeliovich, H., Abildgaard, M. H., Abudu, Y. P., Acevedo-Arozena, A., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1797280 · Cited by 2,897
Self-citationRibosome biogenesis in cancer: new players and therapeutic avenues
Pelletier, J., Thomas, G., & Volarević, S. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.104 · Cited by 812
Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
Skrott, Z., Mistrik, M., Andersen, K. K., Friis, S., Majera, D., Gursky, J., Ozdian, T., Bartkova, J., Turi, Z., Moudry, P., et al. (2017) · Nature · doi:10.1038/nature25016 · Cited by 807
Pharmacological targeting of endoplasmic reticulum stress in disease
Marciniak, S. J., Chambers, J. E., & Ron, D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00320-3 · Cited by 520
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
Hyer, M. L., Milhollen, M. A., Ciavarri, J., Fleming, P., Traore, T., Sappal, D., Huck, J., Shi, J., Gavin, J., Brownell, J., et al. (2018) · Nature Medicine · doi:10.1038/nm.4474 · Cited by 447
Metadata
- Authors
- Anderson, D. J., Le Moigne, R., Djakovic, S., Kumar, B., Rice, J., Wong, S., Wang, J., Yao, B., Valle, E., Kiss von Soly, S., Madriaga, A., Soriano, F., Menon, M.-K., Wu, Z. Y., Kampmann, M., Chen, Y., Weissman, J. S., Aftab, B. T., Yakes, F. M., Shawver, L., Zhou, H.-J., Wustrow, D., & Rolfe, M.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 28
- Issue
- 5
- Pages
- 653-665
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2156739666
- Cited by
- 389
- References
- 55
- FWCI
- 12.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.